Follow-The-Filings

MTNB Matinas Biopharma

Matinas Biopharma earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -0.21
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 3.01,8.01,9.01
10-Q
8-K 1.02
8-K 1.01,3.02,3.03,5.01,5.02,5.03,7.01,8.01,9.01
8-K 3.01,8.01,9.01
424B7
10-Q
8-K 3.01,9.01
10-K
8-K 5.02
8-K 5.02,9.01
8-K 5.02
10-Q
8-K 1.01,3.02,9.01
10-Q
8-K 5.03,9.01
8-K 5.02,5.07,9.01
10-Q
8-K 3.03,5.02,5.08,8.01,9.01
424B3
10-K Period Dec 31, 2024
8-K 3.02,8.01
8-K 5.07
8-K 5.02
8-K 5.02,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jun 10, 2026
4 Period Oct 16, 2025
4 Period Apr 30, 2025 · 3 forms

5 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice